Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
08/2010
08/05/2010US20100197696 Pesticidal heterocyclic dihaloallyl compounds
08/05/2010US20100197655 Sulfonamide derivatives
08/05/2010CA2751176A1 Substituted 1,1,3,3-tetraoxidobenzo[d][1,3,2]dithiazoles as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction
08/05/2010CA2750742A1 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
08/04/2010EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
07/2010
07/29/2010WO2010042652A3 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
07/29/2010US20100190778 3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide derivatives, process for preparation thereof, medicaments containing said derivatives and their use
07/29/2010US20100190777 Compounds and methods for kinase modulation, and indications therefor
07/29/2010US20100189762 Triarylmethane analogs and their use in treating cancers
07/28/2010EP2210597A2 Bacterial virulence modifying agents
07/28/2010CN101787322A Extreme pressure antiwear agent containing ester-based thiadiazole derivative and preparation method thereof
07/28/2010CN101787000A M-stage kinesin inhibitor
07/27/2010US7763732 Indole derivatives
07/27/2010US7763574 Lubricating compositions containing synthetic ester base oil, molybdenum compounds and thiadiazole-based compounds
07/22/2010WO2010083442A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010083441A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010US20100184794 Fused heterocyclic compound
07/22/2010US20100184746 potent antimicrobial activity against macrolide resistant streptococcus pneumococci against which lincomycin and clindamycin are ineffective; therapeutic agents for infectious diseases in respiratory organs
07/22/2010US20100184601 Method and Means Relating to Multiple Herbicide Resistance in Plants
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010CA2747837A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/21/2010EP1981504B1 Thiadiazole derivatives for the treatment of neuro degenerative diseases
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/21/2010CN101781295A 5-amino-1,2,4-thiadiazole compound and preparation method thereof
07/21/2010CN101781274A Acylated piperazine dipeptidyl peptidase IV inhibitor
07/21/2010CN101250167B Heterocyclic compounds containing thiadiazole as well as synthesis and uses thereof
07/21/2010CN101148440B 1,3,4-thiadiazoles derivatives with insect disinfestations effect and preparation method and application thereof
07/20/2010US7759371 Anticancer, antitumor agents, using 2-amino-5-phenyl- (1,3,4)thiadiazoline compounds
07/20/2010US7759370 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
07/20/2010CA2423857C Malonamide and malonamic ester derivatives with antithrombotic activity
07/15/2010WO2010079443A1 Sulfonamide derivatives
07/15/2010CA2747419A1 Sulfonamide derivatives
07/14/2010CN101778835A Method for production of purified ammonium salt of fluorinated bis-sulfonylimide
07/14/2010CN101774982A Deodorization and refining technology of methide as methazolamide synthetic intermediate
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/07/2010EP2203219A1 Substituted benamidines as antibacterial agents
07/07/2010CN101768138A Organic micro-molecular film containing protonized nitrogen atoms and preparation method thereof
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/01/2010WO2010074587A2 5-o-substituted 3-n-aryl-1,3,4-oxadiazolones for medical use
07/01/2010WO2010073011A2 Compounds useful as medicaments
07/01/2010US20100168190 Novel azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (nnrtis) in antiviral therapy (hiv)
07/01/2010US20100168087 Benzo[1,2,3]thiadiazine derivates
07/01/2010DE102008063330A1 New biaxially nematic liquid crystal ring compounds, e.g. (2,5-bis-hexyloxy-4-pyridin-3-yl-ethynyl-phenylethynyl)-phenyl-(1,3,4 )thiadiazol-2-yl-phenylethynyl-2,5-bis-hexyloxy-phenylethynyl-phenoxy -acetic acid ethyl ester, useful in LCD
06/2010
06/30/2010EP2202222A2 Indene derivatives, their preparation and use as medicaments
06/30/2010EP2200991A1 Antibacterial agents
06/30/2010EP1838308B1 [4-(heteroaryl)piperazin-1-yl]-(2,5-substituted -phenyl)methanone derivatives as glycine transporter 1 (glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders
06/29/2010US7745475 Heteroaryl benzamide derivatives as GLK activators
06/29/2010CA2379734C Treatment of cancers
06/24/2010WO2010069794A1 Thiadiazole-substituted arylamides
06/24/2010WO2010069069A1 Cathepsin b inhibitors
06/24/2010US20100160392 Histone deacetylase inhibitors
06/24/2010US20100160343 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160341 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by vla-4
06/24/2010US20100160300 Method of Treating Depression
06/24/2010CA2745290A1 Thiadiazole-substituted arylamides
06/23/2010EP2197851A1 Derivatives of n-phenylacetamide as inhibitors of the enzyme soat1 for pharmaceutical and cosmetic use
06/23/2010CN101754957A Novel heterocyclyl compounds and their use as chemokine antagonists
06/22/2010US7741454 Biological low-molecular-weight derivatives
06/22/2010US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741327 Pyrrolidinone glucokinase activators
06/22/2010US7741320 6,7-dichloro-4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide, used as AMPA receptor modulators for the treatment of anxiety, depression, Parkinson's disease, Pick's disease, Huntington's chorea, Korsakoff's disease and schizophrenia
06/22/2010CA2492161C New derivatives of fluorinated benzothiadiazines, the process for preparing them and the pharmaceutical compounds that contain them
06/17/2010WO2010066697A1 Fungicide hydroximoyl-heterocycles derivatives
06/17/2010WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/17/2010WO2010048207A3 Aryl gpr120 receptor agonists and uses thereof
06/17/2010US20100152254 Alpha-halo- and alpha-alkyl-cyclopropylcarboxy compounds and uses thereof
06/17/2010US20100152203 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/17/2010CA2745843A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
06/16/2010EP2195328A1 Certain chemical entities, compositions, and methods
06/16/2010CN1774428B M-stage kinesin inhibitor
06/15/2010US7737283 Urea substituted with a 5 member nitrogen-containing ring; biological conjugated drug used to modulate of the activation state of p38 kinase protein; antiinflammatory agents; rheumatoid arthritis, asthma, sepsis, toxic shock syndrome, adult respiratory distress syndrome, stroke, reperfusion injury
06/10/2010US20100144709 Thiadiazole derivatives for the treatment of neuro-degenerative diseases
06/10/2010US20100144681 Compounds for the treatment of alzheimer's disease
06/09/2010CN1791585B Cyclic sulfonamides for inhibition of gamma-secretase
06/09/2010CN101723917A Preparation method of 5-amino-1,2,4-thiadiazole-3-acetamide derivative
06/08/2010US7732375 anilide fungicides such as 1,3,5-trimethyl-N-[2-(1,3,3-trimethylbutyl)phenyl]-1H-pyrazole-4-carboxamide, used for controlling unwanted microorganisms
06/03/2010WO2009061652A8 Compounds which modulate the cb2 receptor
06/03/2010WO2009034396A3 Method and means relating to multiple herbicide resistance in plants
06/03/2010US20100137609 Method for producing purified ammonium salt of fluorinated bis-sulfonylimide
06/03/2010US20100137323 Benzo-fused compounds for use in treating metabolic disorders
06/03/2010US20100137298 Biaryl Sulfonamides and Methods for Using Same
06/03/2010US20100133519 Arylamine compounds and electronic devices
06/02/2010EP2190290A2 Method and means relating to multiple herbicide resistance in plants
06/02/2010EP1658263B1 Novel aminobenzophenone compounds
06/02/2010CN101265241B Method for preventing and curing plant disease by increasing plant immunity and use thereof
06/02/2010CN101066972B [1,2,3]-thiobizole derivative and its synthesis process and use
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
05/2010
05/27/2010WO2009129939A3 5-amino-1,2,4-thiadiazole and the derivatives thereof, use thereof for inhibiting or controlling nitrification, and method for the production thereof
05/27/2010US20100130538 Bicyclic compound and pharmaceutical use thereof
05/26/2010CN1918155B Compounds and compositions as LXR modulators
05/26/2010CN1391469B Npyy5拮抗剂 Npyy5 antagonist
05/26/2010CN101712657A heteroarylcarbamoylbenzene derivative
05/26/2010CN101058574B Benzo [1,2,3] thiadiazoles derivatives, synthesis method and use thereof
05/26/2010CN101058564B Aryl alkyl carbamate derivatives production and use thereof in therapy
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 100